Point-of-care Diagnostic Device in Healthcare: A Literature Review
Abstract
Point-of-care (POC) device is an in-vitro diagnostic device utilized by medical professionals near patients, bedside or extra laboratory testing to obtain results quickly and simply and improve the patient care. POC device alert only the crucial data to clinicians or medical professionals. In addition to patient health monitoring, POC devices can be used for cancer, diabetes, and cardiovascular diseases diagnosis (rule – in or rule – out) and management especially in emergency departments, physician office, paramedicine, and mobile units. This review aims to illustrates the use of POC devices for diabetes and cardiovascular management.
Downloads
References
A. Sreeniwas Kumar, Nakul Sinha, Cardiovascular disease in India: A 360-degree overview, Medical Journal of Armed Forces India, 76(2020) 1-3.
Vedika Rathore, Neelima Singh, Roshan Kumar Mahat, Risk Factors for Acute Myocardial Infarction: A Review, Eurasian Journal of Medical Investigation 2018; 2(1); 1-7.
Kristian Thygesen, Joseph S. Alpert, Allan S. Jaffe, Bernard R. Chaitman, Jeroen J. Bax, David A. Morrow, Harvey D. White, Fourth Universal Definition of Myocardial Infarction (2018), Circulation, Volume 138, Issue 20, 13 November 2018; Pages e618-e651.
J S Ladue, F Wroblewski, A Karmen, Serum glutamic oxaloacetic transaminase activity in human acute transmural myocardial infarction, 1954 Sep 24;120(3117):497-9.
HILL BR, LEVI C. Elevation of a serum component in neoplastic disease, in Cancer Research 1954 Aug;14(7):513-5. PMID: 13190533.
N J Schmiechen, C Han, D P Milzman, ED use of rapid lactate to evaluate patients with acute chest pain, Annals of Emergency medicine, 1997 Nov;30(5);571-7
Burton E. Sobel, Gerald F. Bresnahan, William E. Shell, Richard D. Yoder, Estimation of Infarct size in Man and its relation to prognosis, in Circulation 1972;46:640-8.
Wroblewski F. Serum enzyme and isoenzyme alterations in myocardial infarction, Progress in Cardiovascular Diseases, 1963 Jul; 6:63-83.
Bruns DE, Chitwood J, Koller K, et al., Creatine kinaseMB activity: clinical and laboratory studies of specific immunochemical technique with optimized enzymatic assay, Annals of Clinical and Laboratory Science 1983; 13:59-66.
Gilkeson G, Stone MJ, Waterman M, et al., Detection of myoglobin by radioimmunoassay in human sera: its usefulness and limitations as an emergency room screening test for acute myocardial infarction, American Heart Journal 1978; 95:70-7.
Chan DW, Taylor E, Frye T, et al. Immunoenzymatically assay for creatine kinase MB with subunit specific monoclonal antibodies compared with an immunochemical method and electrophoresis, in Clinical Chemistry 1985; 31:465-9.
Alan H.B. Wu, Cardiac Markers: From Enzymes to Proteins, diagnosis to Prognosis, Laboratory to Bedside, Annals of Clinical and Laboratory Science, Vol 29, No. 1, 1999
Vaidya HC, Maynard Y, Dietzler DN, et al., Direct measurement of creatine kinase-MB activity in serum after extraction with a monoclonal antibody specific to the MB isoenzyme, Clinical Chemistry 1986; 32:657-63.
Ebashi S, Kodama A, A new protein factor promoting aggregation of tropomyosin, Journal of Biochemistry 1965; 58:107-8
Cummins B, Auckland ML, Cummins P., Cardiac-specific troponin-I radioimmunoassay in the diagnosis of acute myocardial infarction, American Heart Journal 1987; 113:1333-44.
Katus HA, Remppis A, Looser S, et al., Enzyme-linked immunoassay of cardiac troponin T for the detection of acute myocardial infarction in patients, Journal of Molecular Cell Cardiology 1989; 21:1349-53. 10.1016/0022-2828(89)90680-9.
Katus HA, Looser S, Hallermeyer K, et al., Development and in vitro characterization of a new immunoassay of cardiac troponin T, Clinical Chemistry 1992;38:386-93.
Lippi G, Cervellin G., Genetic polymorphisms of human cardiac troponins as an unrecognized challenge for diagnosing myocardial injury, International Journal of Cardiology 2014; 171:467-70.
Anjith Vupputuri, Saritha Sekhar, Sajitha Krishnan, K. Venugoplan, K.U. Natarajan, Heart-type fatty acid-binding protein (H-FABP) as an early diagnostic biomarker in patients with acute chest pain, Indian Heart Journal 67 (2015), 538-42.
Sibtain Ahmed, Lena Jafri, Performance of cardiac Troponin I: A comparison between the Point of Care testing (POCT) AQT90 Flex and the Siemens Advia Centaur Analyzer in an emergency setting, 2019, Cureus 11(3): e4231.
Fang Zhou, Min Lu, Wei Wang, Zhi-Ping Bian, Jian-Rong Zhang, Jun-Jie Zhu, Electrochemical Immunosensor for Simultaneous Detection of dual cardiac markers based on a Poly (Dimethylsiloxane)- Gold Nanoparticles Composite Microfluidic chip: A proof of principle, Clinical Chemistry 56:11 (2010).
Sibtain Ahmed, Lena Jafri, Ahmed Raheem, Shahid Shakeel, Imran Siddigui, Performance Evaluation of Cardiac Troponin I Assay: A comparison between the Point -of-care Testing Radiometer AQT90 FLEX and the Central Laboratory Siemens, Advia Centaur Analyzer, Cureus, March 2019; 11(3): e4231.
Innam Lee, Xiliang Luo, Jiyong Huang, Xinyan Tracy Cui, Minhee Yun, Detection of cardiac Biomarkers using Single Polyaniline Nanowire-based conductometric Biosensors, Biosensors 2012, 2 205-220.
Jasper Boeddinghaus, Thomas Nestelberger, Luca Koechlin, Desiree Wussler et al, Early diagnosis of Myocardial infarction with point-of-care High-Sensitivity Cardiac Troponin I, Journal of the American college of cardiology Vol. 75, No. 10, 2020.
Michelle L.O’Donoghue, David A. Morrow, Christopher P. Cannon, Petr Jarolim, Nihar R. Desai, Matthew W. Sherwood, Sabina A. Murphy, Robert E. Gerszten and Marc S. Sabatine, Multimarker risk stratification in patients with Acute Myocardial Infarction, Journal of the American Heart Association, 2016, Vol. 5, No. 5.
Christiana Schernthaner, Michael Lichtenauer, Bernhard Wernly, Vera Paar, Rudin Pistulli, Ilonka Rohm, Christian Jung, Hans-Reiner Figulla, Attila Yilmaz, Janne Cadamuro, Elisabeth Haschke-Becher. John Pernow, Paul Christian Schulze, Uta C. Hoppe, Daniel Kretzschmar, Multibiomarker analysis in patients with acute myocardial infarction, European Journal of Clinical Investigation Vol 47, 2017.
Kaige Zhao, Min Tang, Huaisheng Wang, Zhenxian Zhou, Yafeng Wu, Songqin Liu,, Simultaneous detection of three biomarkers related to acute myocardial infarction based on immunosensing biochip, Biosensors and Bioelectronics 126(2019) 767-772.
Anouk van Hooij, Elisa M. Tjon Kon Fat, Danielle de Jong, Marufa Khatun, Santosh Soren, Abu Sufian Chowdhury, Johan Chandra Roy, Khorshed Alam, Jong-Pill Kim, Jan Hendrik Richardus, Annemieke Geluk, Paul L.A.M. Corstjens, Prototype multi-biomarker test for point-of-care leprosy diagnostics, iScience 24, 102006, January 22, 2021.
Can Dincer, Richard Bruch, Andre Kling, Petra S. Dittrich, Gerald A. Urban, Multiplexed Point-of-care – xPOCT, Trends Biotechnology, 2017 Aug; 35(8): 728-742.
8. Singer AJ, Ardise J, Gulla J, Cangro J. Point-of-care testing reduces length of stay in emergency department chest pain patients, Annal Emergency of Medicine 2005; 45:587–91.
Apple FS, Chung AY, Kogut ME, Bubany S, Murakami MAM. Decreased patient charges following implementation of point-of-care cardiac troponin monitoring in acute coronary syndrome patients in a community hospital cardiology unit, Clinical Chimica Acta 2006; 370:191–5.
Pickering JW, Young JM, George PM, et al., Validity of a novel point-of-care troponin assay for single-test rule-out of acute myocardial infarction, JAMA Cardiology 2018; 3:1108–12.
Santanu Guha, Rishi Sethi, Saumithra Ray, Vinay K Bahl, S. Shanmugasundaram, Prafula Kerkar, Sivasubramanian Ramakrishnan, Rakesh Yadav, Gaurav Chaudary et al, Cardiological society of India: Position statement for the management of ST elevation myocardial infarction in India, Journal of Indian Heart 2017 Apr; 69 (Suppl 1): S63 – S97.
Francesca di serio, Marco Captuto, Martina Zaninotto, Cosmino Ottomano, Evaluation of analytical performance of the PATHFAST cardiac troponin, Clinical Chemistry and Laboratory Medicine, June 2009; 47(7); 829-833.
David R. Whiting, Lenor Guriguata, Clara Weil, Jonathan Shaw, IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030, Diabetes Research and Clinical Practice, Volume 94, Issue 3, December 2011, Pages 311-321.
Kost GJ. Goals, guidelines, and principles for point of care testing. In: Kost GJ, ed. Principles and practice of point of care testing, Philadelphia, PA: Lippincott Williams and Wilkins; 2002.
Nichols J., Point of Care Testing – Performance Improvement and Evidence Based Outcomes, New York, NY: Marcel Decker, Inc.; 2003.
Clarke SF, Foster JR., A history of blood glucose meters and their role in self-monitoring of diabetes mellitus, British Journal of Biomedical Science 2012;69(2):83-93.
Johnson G., Clinical lecture on the various modes of testing for sugar in the urine. British Medical Journal 1884;1(1201):1-4.
Benedict SR., A reagent for the detection of reducing sugars 1908. Journal of Biological Chemistry 2002;277(16): e5.
Free AH, Adams EC, Kercher ML, Free HM, Cook MH., Simple specific test for urine glucose, Clinical Chemistry 1957;3(3):163-168.
Kohn J., A rapid method of estimating blood-glucose ranges, Lancet. 1957;273(6986):119-121.
Free AH, Free HM., Self-testing, an emerging component of clinical chemistry, Clinical Chemistry 1984;30(6):829-838.
Mendosa D , History of blood glucose meters: transcripts of interviews 2006, Available at: http://www.mendosa.com/history.htm.
BCCResearch. Point of Care Diagnostics (Report code HLC043C) BCC Research; 2012. Available t: http://www.bccresearch.com/market-research/healthcare/point-of-care-diagnostics-market-hlc043c.html
Copyright (c) 2021 Ramya Devaraj
This work is licensed under a Creative Commons Attribution 4.0 International License.
I/We agree with the provision of the Bye-Law 118 of The Institution of Engineers (India) which states that copyright of each paper published in Institution Journal or Annual Technical Volume in full or in Abstract at its centres shall lie with the Institution.
